bioRxiv is receiving many new papers on coronavirus SARS-CoV-2.   A reminder: these are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information.

COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

4423 Articles (3572 medRxiv, 851 bioRxiv)

Most recent first Page 1: Articles 1-10  | Next

Investigation of subsequent and co-infections associated with SARS-CoV-2 (COVID-19) in hospitalized patients
Crotty, M. P., Dominguez, E. A., Akins, R., Nguyen, A. T., Slika, R., Rahmanzadeh, K., Wilson, M.
10.1101/2020.05.29.20117176 — Posted: 2020-05-30
SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures
Appa, A., Chamie, G., Sawyer, A., Baltzell, K., Dippel, K., Ribeiro, S., Duarte, E., Vinden, J., Consortium, C., Kramer-Feldman, J., Rahdari, S., MacIntosh, D., Nicholson, K., Im, J., Havlir, D., Greenhouse, B.
10.1101/2020.05.29.20116426 — Posted: 2020-05-30
When to relax a lockdown? A modelling-based study of testing-led strategies coupled with sero-surveillance against SARS-CoV-2 infection in India
Mandal, S., Das, H., Deo, S., Arinaminpathy, N.
10.1101/2020.05.29.20117010 — Posted: 2020-05-30
Efficacy and safety of interferon beta-1a in treatment of severe COVID-19: A randomized clinical trial
Davoudi-Monfared, E., Rahmani, H., Khalili, H., Hajiabdolbaghi, M., Salehi, M., Abbasian, L., Kazemzadeh, H., Yekaninejad, M. S.
10.1101/2020.05.28.20116467 — Posted: 2020-05-30
Using real-world contact networks to quantify theeffectiveness of digital contact tracing and isolation strategies for Covid-19 pandemic
Cencetti, G., Santin, G., Longa, A., Pigani, E., Barrat, A., Cattuto, C., Lehmann, S., Lepri, B.
10.1101/2020.05.29.20115915 — Posted: 2020-05-30
Social Distancing Interventions in the United States: An Exploratory Investigation of Determinants and Impacts
Guo, S., An, R., McBride, T. D., Yu, D., Fu, L., Yang, Y.
10.1101/2020.05.29.20117259 — Posted: 2020-05-30
Head-to-head comparison of four antigen-based rapid detection tests for the diagnosis of SARS-CoV-2 in respiratory samples
Weitzel, T., Legarraga, P., Iruretagoyena, M., Pizarro, G., Vollrath, V., Araos, R., Munita, J. M., Porte, L.
10.1101/2020.05.27.119255 — Posted: 2020-05-30
Mortality rate and estimate of fraction of undiagnosed COVID-19 cases in the US in March and April 2020
Gao, R., Rosenlof, K. H.
10.1101/2020.05.28.20116095 — Posted: 2020-05-30
Monitoring the post-containment COVID-19 crisis in Guadeloupe: Early-warning signals of destabilisation through bootstrapped probability density functions
ALLALI, M., Portecop, P., Carles, M., Gibert, D.
10.1101/2020.05.29.20117333 — Posted: 2020-05-30
An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemic
Degeling, K., Baxter, N. N., Emery, J., Franchini, F., Gibbs, P., Mann, G. B., McArthur, G., Solomon, B. J., IJzerman, M. J.
10.1101/2020.05.30.20117630 — Posted: 2020-05-30

RSS  Collection RSS | JSON

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).